Reuters logo
BRIEF-AB Science announces positive phase 2 clinical study of Masitinib
March 12, 2015 / 6:12 PM / 3 years ago

BRIEF-AB Science announces positive phase 2 clinical study of Masitinib

March 12 (Reuters) - AB Science SA :

* Announces positive efficacy and safety results from phase 2 study with Masitinib in patients with triple negative breast cancer (TNBC) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below